The price of WAR: AMR
- PMID: 40395972
- PMCID: PMC12089782
- DOI: 10.1093/jacamr/dlaf083
The price of WAR: AMR
Abstract
Background: The ongoing conflict in Ukraine has exacerbated the risk of MDR bacterial infections in war-injured patients.
Methods: We present the case of a Ukrainian soldier who sustained a traumatic explosive injury to the bilateral lower extremities, underwent surgery and subsequently experienced an infection with a carbapenem-resistant Klebsiella pneumoniae. The isolate was subject to genomic WGS.
Results: This case study describes the successful management of a traumatic injury in a Ukrainian soldier infected with a carbapenem-resistant K. pneumoniae isolated from surgical wounds. WGS revealed a hypervirulent ST147 strain carrying multiple resistance and virulence factors, including bla NDM-1. Treatment with ceftazidime/avibactam and aztreonam was effective.
Conclusions: Ceftazidime/avibactam and aztreonam is highlighted as a promising regimen for MDR infections in conflict zones.
Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy 2025.
Figures


References
Grants and funding
LinkOut - more resources
Full Text Sources